Holdings of ACORN CAPITAL ADVISORS, LLC
19 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 92.7 % of the equity sleeve
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 100.0 %
Shares computed on the equity sleeve.
| Country | Lines | Value | Share |
|---|---|---|---|
| US | 19 | 313.4M $ | 100.00 % |
Positions
| Company | Shares | Value | Weight |
|---|---|---|---|
| Terns Pharmaceuticals Inc | 1,746,264 | 92.1M $ | |
| CG oncology Inc | 1,130,501 | 76.6M $ | |
| Puma Biotechnology Inc | 4,131,299 | 26.4M $ | |
| Trevi Therapeutics Inc | 2,144,844 | 25.6M $ | |
| Candel Therapeutics Inc | 3,497,948 | 17.2M $ | |
| Bicara Therapeutics Inc | 643,382 | 12.8M $ | |
| OnKure Therapeutics Inc | 2,839,674 | 11.8M $ | |
| JADE BIOSCIENCES INC | 786,760 | 11.1M $ | |
| Protara Therapeutics Inc | 1,752,115 | 9.1M $ | |
| Verastem Inc | 1,469,153 | 7.8M $ | |
| LeonaBio Inc | 634,539 | 6.5M $ | |
| Aura Biosciences Inc | 595,744 | 4M $ | |
| Aadi Bioscience Inc | 1,139,363 | 3.9M $ | |
| Cardiff Oncology Inc | 1,762,084 | 2.9M $ | |
| Q32 Bio Inc | 315,052 | 2M $ | |
| Karyopharm Therapeutics Inc | 287,826 | 1.6M $ | |
| JASPER THERAPEUTICS INC | 1,411,492 | 1.2M $ | |
| BIOATLA INC | 5,406,345 | 865K $ | |
| VYNE THERAPEUTICS INC | 1,425 | 855 $ |